Sosei Heptares' Partner, Pfizer, Progresses Its GLP-1
PF-06954522 was introduced into Pfizer’s Internal Medicine focused clinical pipeline as part of its Q3 2023 results presentation Tokyo, Japan and...
Source: globenewswire.com
Page 3 - Sosei Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sosei Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sosei Group Today - Breaking & Trending Today
Daridorexant for Insomnia Nears Approval in Japan
A new drug application has been submitted in Japan for the approval of daridorexant, a dual orexin receptor antagonist for insomnia.
Source: sleepreviewmag.com
Idorsia Shares Fall on Funding Needs
By Helena Smolak Idorsia shares fell after the company said it continues to look for funding, given that a recent sale of assets to Sosei Group and cost...
Source: marketwatch.com
4565 Stock Price | Sosei Group Corp. Stock Quote (Japan: Tokyo)
4565 | Complete Sosei Group Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Source: marketwatch.com
Sosei Heptares and Verily Nominate First G-protein-coupled receptor Target for Therapeutic Development
Nomination of novel drug target based on insights generated through application of Verily’s Immune Profiler platform and Sosei Heptares’ GPCR-focused structure-based drug design expertise ...
Source: marketscreener.com